These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19658090)

  • 1. Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants.
    Illigens BM; Yamada A; Anosova N; Dong VM; Sayegh MH; Benichou G
    Eur J Immunol; 2009 Nov; 39(11):3000-9. PubMed ID: 19658090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of autoimmunity after skin graft rejection via an indirect alloresponse.
    Valujskikh A; Fedoseyeva E; Benichou G; Heeger PS
    Transplantation; 2002 Apr; 73(7):1130-7. PubMed ID: 11965045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation.
    Boisgérault F; Liu Y; Anosova N; Ehrlich E; Dana MR; Benichou G
    J Immunol; 2001 Aug; 167(4):1891-9. PubMed ID: 11489968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts.
    Surquin M; Le Moine A; Flamand V; Rombaut K; Demoor FX; Salmon I; Goldman M; Abramowicz D
    Transplantation; 2005 Nov; 80(10):1485-92. PubMed ID: 16340795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and th2 alloimmune responses.
    Niederkorn JY; Chen PW; Mellon J; Stevens C; Mayhew E
    J Immunol; 2010 Jun; 184(11):6076-83. PubMed ID: 20410484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
    Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
    J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response.
    Csencsits K; Wood SC; Lu G; Magee JC; Eichwald EJ; Chang CH; Bishop DK
    Eur J Immunol; 2005 Mar; 35(3):843-51. PubMed ID: 15714582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation.
    Popov IA; Fedoseyeva EV; Orr PL; Garovoy MR; Benichou G
    Transplantation; 1995 Dec; 60(12):1621-4. PubMed ID: 8545902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants.
    Fedoseyeva EV; Kishimoto K; Rolls HK; Illigens BM; Dong VM; Valujskikh A; Heeger PS; Sayegh MH; Benichou G
    J Immunol; 2002 Aug; 169(3):1168-74. PubMed ID: 12133936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.
    Simeonovic CJ; Townsend MJ; Karupiah G; Wilson JD; Zarb JC; Mann DA; Young IG
    Cell Transplant; 1999; 8(4):365-73. PubMed ID: 10478716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 T cells can reject major histocompatibility complex class I-deficient skin allografts.
    He C; Heeger PS
    Am J Transplant; 2004 May; 4(5):698-704. PubMed ID: 15084163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses.
    Li XC; Zand MS; Li Y; Zheng XX; Strom TB
    J Immunol; 1998 Sep; 161(5):2241-7. PubMed ID: 9725217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice.
    Valujskikh A; Matesic D; Gilliam A; Anthony D; Haqqi TM; Heeger PS
    J Clin Invest; 1998 Mar; 101(6):1398-407. PubMed ID: 9502782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts.
    Lee RS; Grusby MJ; Laufer TM; Colvin R; Glimcher LH; Auchincloss H
    Transplantation; 1997 Apr; 63(8):1123-33. PubMed ID: 9133474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway.
    Mariotti J; Foley J; Ryan K; Buxhoeveden N; Kapoor V; Amarnath S; Fowler DH
    Blood; 2008 Dec; 112(12):4765-75. PubMed ID: 18625883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.